Issued Patents All Time
Showing 1–24 of 24 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12145917 | Crystalline forms of a compound for treating or preventing gout or hyperuricemia | Shunqi Yan, Litain YEH, Ruiping Wang | 2024-11-19 |
| 11236081 | Crystalline salts of corydalmine | Zheng-Yu Yang, Zhicong Shi | 2022-02-01 |
| 9981961 | Deoxycytidine kinase inhibitors | Caius G. Radu, Raymond M. Gipson, Jue Wang, Nagichettiar Satyamurthy, Arnon Lavie +3 more | 2018-05-29 |
| 9598404 | Deoxycytidine kinase inhibitors | Caius G. Radu, Raymond M. Gipson, Jue Wang, Nagichettiar Satyamurthy, Arnon Lavie +3 more | 2017-03-21 |
| 7960407 | Crystal forms of an imidazole derivative | Naoaki Haruta, Tomoki Kato, Toyoharu Numata, Andrew Trask | 2011-06-14 |
| 7803805 | Cristalline 3-{(3R,4R)-4 methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile mono citrate salt | Mark E. Flanagan | 2010-09-28 |
| 7309782 | Crystal forms of azithromycin | Andrew Trask | 2007-12-18 |
| 7307156 | Crystal forms of azithromycin | Andrew Trask, Joseph E. Mertz | 2007-12-11 |
| 7282486 | Crystal forms of azithromycin | Andrew Trask | 2007-10-16 |
| 7144915 | Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) | Stephen R. Byrn, David Coates, Karen S. Gushurst, Joseph Francis Krzyzaniak, Henry Morrison +2 more | 2006-12-05 |
| 7105179 | Crystal forms of azithromycin | Andrew Trask | 2006-09-12 |
| 7081525 | Crystal forms of azithromycin | Andrew Trask | 2006-07-25 |
| 7053192 | Crystal forms of azithromycin | Andrew Trask | 2006-05-30 |
| 6977243 | Crystal forms of azithromycin | Andrew Trask | 2005-12-20 |
| 6965027 | Crystalline 3-{4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile citrate | Mark E. Flanagan | 2005-11-15 |
| 6949652 | Crystalline forms of 3-isopropyl-6-[4-(2,5-difluoro-phenyl)-oxazol-5-yl]-[1,2,4]triazolo-[4,3-A]pyridine | Ming Kang, Zhengong Bryan Li, Yong Tao | 2005-09-27 |
| 6861413 | Stable non-dihydrate azithromycin oral suspensions | Andrew Trask | 2005-03-01 |
| 6844349 | Salt forms of E-2-methoxy-N-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production | John Charles Kath, Daniel Tyler Richter, Andrew Trask | 2005-01-18 |
| 6734308 | Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-(3-ethynyl-phenyl)-1-methyl-1H-quinolin-2-one, 2,3,- dihydroxybutanedioate salts and method of production | Joseph P. Lyssikatos, Derek Tickner, Linda Newton, Clifford N. Meltz | 2004-05-11 |
| 6683106 | N-(indole-2-carbonyl)-b-alaninamide crystal forms | Douglas J. M. Allen, Frank R. Busch, Joseph Francis Krzyzaniak, Susan Orrill, Peter R. Rose +2 more | 2004-01-27 |
| 6645982 | Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-(3-ethynyl-phenyl)-1-methyl-1H-quinolin-2-one, 2,3-dihydroxybutanedioate salts and method of production | Joseph P. Lyssikatos, Derek Tickner, Linda Newton, Clifford N. Meltz | 2003-11-11 |
| 6605729 | Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-&bgr;,&dgr;-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) | Stephen R. Byrn, David Coates, Karen S. Gushurst, Joseph Francis Krzyzaniak, Henry Morrison +2 more | 2003-08-12 |
| 6486168 | Formulations and methods for treatment of mucosal associated conditions with an immune response modifier | Raymond D. Skwierczynski, Kenneth R. Phares, Richard L. Miller, Michael J. Jozwiakowski, Terri F. Busch | 2002-11-26 |
| 6245776 | Formulations and methods for treatment of mucosal associated conditions with an immune response modifier | Raymond D. Skwierczynski, Kenneth R. Phares, Richard L. Miller, Michael J. Jozwiakowski, Terri F. Busch | 2001-06-12 |